Free Trial
NASDAQ:SERA

Sera Prognostics (SERA) Stock Price, News & Analysis

Sera Prognostics logo
$2.97 +0.27 (+10.00%)
As of 03:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Sera Prognostics Stock (NASDAQ:SERA)

Key Stats

Today's Range
$2.70
$2.93
50-Day Range
$1.49
$4.09
52-Week Range
$1.37
$9.13
Volume
38,626 shs
Average Volume
179,026 shs
Market Capitalization
$111.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sera Prognostics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
8th Percentile Overall Score

SERA MarketRank™: 

Sera Prognostics scored higher than 8% of companies evaluated by MarketBeat, and ranked 902nd out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Sera Prognostics.

  • Earnings Growth

    Earnings for Sera Prognostics are expected to decrease in the coming year, from ($0.96) to ($0.98) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sera Prognostics is -3.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sera Prognostics is -3.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Sera Prognostics has a P/B Ratio of 2.05. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Sera Prognostics' valuation and earnings.
  • Percentage of Shares Shorted

    5.50% of the float of Sera Prognostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Sera Prognostics has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Sera Prognostics has recently increased by 46.32%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Sera Prognostics does not currently pay a dividend.

  • Dividend Growth

    Sera Prognostics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.50% of the float of Sera Prognostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Sera Prognostics has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Sera Prognostics has recently increased by 46.32%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Sera Prognostics has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Sera Prognostics this week, compared to 2 articles on an average week.
  • Search Interest

    3 people have searched for SERA on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Sera Prognostics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $128,049.00 in company stock.

  • Percentage Held by Insiders

    15.80% of the stock of Sera Prognostics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    54.64% of the stock of Sera Prognostics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Sera Prognostics' insider trading history.
Receive SERA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sera Prognostics and its competitors with MarketBeat's FREE daily newsletter.

SERA Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

SERA Stock Analysis - Frequently Asked Questions

Sera Prognostics' stock was trading at $8.14 at the start of the year. Since then, SERA stock has decreased by 64.7% and is now trading at $2.87.

Sera Prognostics, Inc. (NASDAQ:SERA) issued its quarterly earnings results on Wednesday, May, 14th. The company reported ($0.20) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.24) by $0.04. The business had revenue of $0.04 million for the quarter, compared to the consensus estimate of $0.06 million. Sera Prognostics had a negative trailing twelve-month return on equity of 51.35% and a negative net margin of 28,685.22%.
Read the conference call transcript
.

Sera Prognostics (SERA) raised $75 million in an initial public offering on Thursday, July 15th 2021. The company issued 4,687,500 shares at $15.00-$17.00 per share.

Shares of SERA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sera Prognostics investors own include Meta Platforms (META), JPMorgan Chase & Co. (JPM), Tesla (TSLA), NVIDIA (NVDA), Netflix (NFLX), Advanced Micro Devices (AMD) and Home Depot (HD).

Company Calendar

Last Earnings
5/14/2025
Today
7/16/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:SERA
CIK
1534969
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.94)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.90 million
Net Margins
-28,685.22%
Pretax Margin
-28,685.22%
Return on Equity
-51.35%
Return on Assets
-37.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.02
Quick Ratio
2.02

Sales & Book Value

Annual Sales
$80 thousand
Price / Sales
1,269.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.40 per share
Price / Book
1.93

Miscellaneous

Outstanding Shares
37,670,000
Free Float
31,721,000
Market Cap
$101.52 million
Optionable
Optionable
Beta
0.99
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:SERA) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners